Navigation Links
KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
Date:11/13/2008

s and Exchange Commission, to the Company's pending or potential future litigations, and to the timing of the completion of the Audit Committee's inquiry, and all statements pertaining to product development, product launches, regulatory approvals, expectations of the impact of R&D and marketing and promotional expenditures, the return to liquidity of the Company's auction rate securities, litigations involving the Company's ANDA filings, market position, acquisitions, market potential for sales of the Company's products, revenues, expenditures and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, KV provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing and labeling, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the introduction and impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Lynchburg, Va. (PRWEB) January 22, 2015 Liberty ... Health Counseling (M.A.) program from the Council for ... The program, part of Liberty’s Center for Counseling & ... Hawkins, founding dean of the university’s new School of Behavioral ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... Among breast cancer patients, both chemotherapy and tamoxifen independently reduced ... breast, according to a study published online December 25 in ... risk reduction persisted for at least 10 and 5 years, ... developing cancer in the other breast is two to six ...
... genetic mutation already known to be more common in ... Hispanic and young African-American women with breast cancer, according ... mutation to date. , Researchers at the Stanford University ... reported the finding from a study of 3,181 breast ...
... taking things as they come, expert says , MONDAY, Dec. ... and social stress, and memories of lost loved ones can ... lead to seasonal blues during the holidays, says an expert ... expect difficult relationships to improve just because it,s Christmas are ...
... Dec. 24 QMed, Inc., (Nasdaq:,QMED) today announced that ... the last 30 business days, the bid price of ... per share requirement for,continued inclusion under Marketplace Rule 4310(c)(4) ... (D), the Company,will be provided 180 calendar days, or ...
... HARBIN, China, Dec. 24 /Xinhua-PRNewswire-FirstCall/ -- China Sky ... marketer and,distributor of pharmaceutical, medicinal and diagnostic products ... & Co., LLP as its independent,auditor, effective immediately. ... China Sky One Medical, Inc. stated, "We are ...
... Therapeutics Inc.,("Transition" or the "Company") (TSX: TTH; NASDAQ: ... US$5million milestone payment under its,global collaboration agreement with ... ELN ). The milestone payment was triggered by ... Alzheimer,s disease drug candidate, ELND005,(AZD-103), which was jointly ...
Cached Medicine News:Health News:Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds 2Health News:Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds 3Health News:Realistic Expectations Help Ward Off Holiday Depression 2Health News:QMed, Inc. Receives NASDAQ Letter 2Health News:China Sky One Medical Appoints Independent Auditor 2Health News:Transition Therapeutics Announces Milestone Payment from Elan 2
(Date:1/22/2015)... NEWBURY PARK, Calif. , Jan. 22, 2015 ... drive the continued consolidation of localization purchasing in 2015, ... According to a recent study by market ... studied chose a single-source solution for their translation and ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... addition of the "Microbiology Testing/Clinical Microbiology Market ... Global Forecast to 2019" report to their ... wide array of techniques for the detection of ...
(Date:1/22/2015)... Parenteral Drug Association (PDA) today announced the launch of its ... Future. The Manufacturing Science Program SM ... the ongoing focus PDA has on pharmaceutical and biopharmaceutical manufacturing. ... gaps in current manufacturing science as well as gaps that ...
Breaking Medicine Technology:Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
...  Bayer HealthCare is pleased to announce two employees have ... (HBA). They were honored at the annual HBA Woman ... May 3. Mary Puncochar, Area Sales Manager, ... Laura Schwieterman, Senior Brand Manager, U.S. Marketing, Bayer HealthCare ...
... Reportlinker.com announces that a new market research ...   Antithrombotic/Anticoagulant ... http://www.reportlinker.com/p0325493/Antithrombotic/Anticoagulant-Drugs-World-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication   ... Where are antithrombotic and anticoagulant ...
Cached Medicine Technology:Bayer Employees Named Rising Stars by Healthcare Businesswomen's Association 2Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 2Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 3Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 4Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 5Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 6Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 7Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 8Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 9Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 10Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 11
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
A straightforward, versatile approach to arthroscopically assisted pin placement in either the ankle or wrist....
... The BTA stat Test is ... the qualitative detection of bladder ... diagnosed with bladder cancer. This ... an aid in the management of ...
ThyroTest by ThyroTec, Inc. is a rapid immunoassay, similar to a rapid pregnancy test. By using 2 drops of blood from a finger stick and 5 drops of diluent, a qualitative TSH level is inicated in min...
Medicine Products: